Luc Debruyne currently serves as the Chairman of the Board at Bavarian Nordic and FundPlus, in addition to being a Board Member for several organizations, including VIB and GreenLight Biosciences, Inc. Debruyne is also a Professor at KU Leuven in the Faculty of Medicine, focusing on the Biomedical Sciences Group, and holds the position of Non-Executive Director at UZ Leuven. Previously, Debruyne was a strategy advisor to the CEO at CEPI and served in various senior roles at GSK, culminating as President of Global Vaccines. Debruyne holds a Master's Degree in Physical Education from KU Leuven and has an educational background from the University of Cambridge.